Cargando…

Identification and Validation of an Annexin-Related Prognostic Signature and Therapeutic Targets for Bladder Cancer: Integrative Analysis

SIMPLE SUMMARY: Identification of new prognostic biomarkers and therapeutic targets could be essential ways to improve the outcome of bladder cancer (BC) patients. In this study, we comprehensively analyzed the mRNA expression and prognosis of Annexin family members (ANXA1-11, 13) in BC through publ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Xitong, Qi, Xinlei, Wang, Yao, Zhang, Baokun, He, Tianshuai, Yan, Taoning, Zhang, Lu, Wang, Yange, Zheng, Hong, Zhang, Guosen, Guo, Xiangqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869209/ https://www.ncbi.nlm.nih.gov/pubmed/35205125 http://dx.doi.org/10.3390/biology11020259

Ejemplares similares

A Comprehensive Prognostic Analysis of Tumor-Related Blood Group Antigens in Pan-Cancers Suggests That SEMA7A as a Novel Biomarker in Kidney Renal Clear Cell Carcinoma
por: Wang, Yange, et al.
Publicado: (2022)

OSblca: A Web Server for Investigating Prognostic Biomarkers of Bladder Cancer Patients
por: Zhang, Guosen, et al.
Publicado: (2019)

Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer
por: Sun, Xianchao, et al.
Publicado: (2021)

Analysis of the Expression and Prognostic Value of Annexin Family Proteins in Bladder Cancer
por: Wu, WenBo, et al.
Publicado: (2021)

Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer
por: Zhao, Kai, et al.
Publicado: (2021)

A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer
por: Yan, Yilin, et al.
Publicado: (2021)

Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer
por: Xu, Fei, et al.
Publicado: (2021)

Genome-Wide Analyses of Prognostic and Therapeutic Alternative Splicing Signatures in Bladder Urothelial Carcinoma
por: Fan, Zhongru, et al.
Publicado: (2021)

Individualized prognostic signature for pancreatic carcinoma validated by integrating immune-related gene pairs (IRGPs)
por: Li, Yecheng, et al.
Publicado: (2021)

Prognostic implications of an autophagy-based signature in colorectal cancer
por: Wang, Liangbin, et al.
Publicado: (2021)

Identification and validation of an 18-gene signature highly-predictive of bladder cancer metastasis
por: Wang, Beihe, et al.
Publicado: (2018)

Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins
por: Gou, Rui, et al.
Publicado: (2019)

A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
por: Cai, Jinming, et al.
Publicado: (2023)

OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma
por: An, Yang, et al.
Publicado: (2020)

Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis
por: Kang, Yao, et al.
Publicado: (2021)

OSucs: An Online Prognostic Biomarker Analysis Tool for Uterine Carcinosarcoma
por: An, Yang, et al.
Publicado: (2020)

OSov: An Interactive Web Server to Evaluate Prognostic Biomarkers for Ovarian Cancer
por: Yan, Zhongyi, et al.
Publicado: (2021)

Systematic Review of Prognostic Gene Signature in Gastric Cancer Patients
por: Xie, Longxiang, et al.
Publicado: (2020)

Compounds targeting YadC of uropathogenic Escherichia coli and its host receptor annexin A2 decrease bacterial colonization in bladder
por: Li, Xiao, et al.
Publicado: (2019)

Risk factors for in-hospital mortality in patients with cancer and COVID-19
por: Zhang, Guosen, et al.
Publicado: (2020)

An Individualized Prognostic Signature for Clinically Predicting the Survival of Patients With Bladder Cancer
por: Liu, Qing, et al.
Publicado: (2022)

In Silico Establishment and Validation of Novel Lipid Metabolism-Related Gene Signature in Bladder Cancer
por: Sun, Xianchao, et al.
Publicado: (2022)

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
por: Wang, Ruiliang, et al.
Publicado: (2021)

Construction and validation of an eight-gene signature with great prognostic value in bladder cancer
por: Yan, Xin, et al.
Publicado: (2020)

Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer
por: Yan, Xin, et al.
Publicado: (2021)

OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma
por: An, Yang, et al.
Publicado: (2020)

Expression levels and prognostic values of annexins in liver cancer
por: Zhuang, Chunbo, et al.
Publicado: (2019)

Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer
por: Choi, Chel Hun, et al.
Publicado: (2016)

Upregulated expression of Annexin II is a prognostic marker for patients with gastric cancer
por: Zhang, Qi, et al.
Publicado: (2012)

Integrated bioinformatic analysis identified a novel prognostic pan-programmed cell death signature for bladder cancer
por: Zhang, Lusi, et al.
Publicado: (2022)

Quantitative Proteomic Profiling the Molecular Signatures of Annexin A5 in Lung Squamous Carcinoma Cells
por: Sun, Bing, et al.
Publicado: (2016)

Therapeutic Potential of Annexins in Sepsis and COVID-19
por: Mui, Louise, et al.
Publicado: (2021)

Potential prognostic and therapeutic value of ANXA8 in renal cell carcinoma: based on the comprehensive analysis of annexins family
por: Wang, Li-Hui, et al.
Publicado: (2023)

Novel Model for Comprehensive Assessment of Robust Prognostic Gene Signature in Ovarian Cancer Across Different Independent Datasets
por: Bing, Zhitong, et al.
Publicado: (2019)

Identification and validation of a twelve immune infiltration-related lncRNA prognostic signature for bladder cancer
por: Liu, Chen-Qian, et al.
Publicado: (2022)

Identify and validate RUNX2 and LAMA2 as novel prognostic signatures and correlate with immune infiltrates in bladder cancer
por: Jin, Yi, et al.
Publicado: (2023)

Identification and validation of a prognostic four-genes signature for hepatocellular carcinoma: integrated ceRNA network analysis
por: Yan, Yongcong, et al.
Publicado: (2019)

Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer
por: Wang, Jing, et al.
Publicado: (2019)

Identification of a six-gene prognostic signature for bladder cancer associated macrophage
por: Jiang, Yunzhong, et al.
Publicado: (2022)

Therapeutic potential for targeting Annexin A1 in fibrotic diseases
por: Yan, Zhibin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3kd96gqbeqc08bvcvmq7rma1n7